Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses
NCT04380779 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2430
Last updated 2020-12-14
Summary
The main objectives are:
* To establish the prevalence of major bleeding in patients treated with higher than recommended thromboprophylaxis doses.
* To identify variables associated to higher risk of bleeding.
Conditions
Sponsors & Collaborators
-
Manuel Monreal
lead OTHER
Principal Investigators
-
Manuel Monreal · Germans Trias i Pujol Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-13
- Primary Completion
- 2020-10-13
- Completion
- 2020-10-13
Countries
- Spain
Study Locations
More Related Trials
-
COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection
NCT04787510 ·Status: COMPLETED
-
A Multifaceted Intervention to Improve Bleeding Management Among Patients Using Oral Anticoagulants (IMPACT-BLEEDING)
NCT06575517 ·Status: WITHDRAWN
-
Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients
NCT04412304 ·Status: COMPLETED
-
Unleash the Mystery of COVID-19 Related Unusual Thrombosis
NCT05068375 ·Status: UNKNOWN
-
Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection
NCT04651400 ·Status: COMPLETED
-
Andexanet Alfa and 4F-PCC Use in Patients Hospitalised With an Anticoagulant-related Major Bleed
NCT05548777 ·Status: COMPLETED
-
Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)
NCT04372589 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients
NCT04593654 ·Status: COMPLETED
-
Thrombosis and Covid-19
NCT04366778 ·Status: COMPLETED
-
Reversal of the Antithrombotic Action of New Oral Anticoagulants
NCT01478282 ·Status: UNKNOWN ·Phase: PHASE4
-
Practice Variation on Antithrombotics in COVID-19
NCT04998799 ·Status: COMPLETED
-
A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic
NCT04444700 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis
NCT04650087 ·Status: COMPLETED ·Phase: PHASE3
-
Analysis of the Coagulopathy Developed by COVID-19 Infected Patients
NCT04356950 ·Status: COMPLETED
-
Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto
NCT04393805 ·Status: COMPLETED
-
Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic
NCT04400877 ·Status: COMPLETED
-
COVID-19 and Venous Thromboembolism Risk
NCT04569344 ·Status: COMPLETED
-
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
NCT05848713 ·Status: RECRUITING ·Phase: PHASE3
-
Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care
NCT04362085 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19
NCT04367662 ·Status: COMPLETED ·Phase: NA
-
Description of a Cohort of Covid-19 Patients With a Circulating Anticoagulant
NCT05075928 ·Status: UNKNOWN
-
Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients
NCT04492254 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection
NCT04508439 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19
NCT04745442 ·Status: COMPLETED ·Phase: PHASE2
-
Hamburg Edoxaban for Anticoagulation in COVID-19 Study
NCT04542408 ·Status: COMPLETED ·Phase: PHASE3